Danaher Corporation operates in the healthcare sector, focusing on designing, manufacturing, and marketing innovative products and services. Its core offerings include life sciences, diagnostics, and environmental and applied solutions. Major business segments consist of Life Sciences, Diagnostics, and Water Quality, with primary revenue sources stemming from laboratory instruments, reagents, and software solutions that enhance healthcare and environmental testing.
The investment profile of Danaher is more aligned with balanced investors, given its moderate dividend yield and growth potential. The company demonstrates consistent revenue growth, making it suitable for those seeking a combination of capital appreciation and income. Its established market position and diversified product range contribute to a stable investment outlook.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-11 05:18 | Hold | Sell | Weak fundamentals and negative momentum raise concerns. |
| 2026-05-16 02:33 | Sell | Hold | Weak momentum and high risk; cautious approach advised. |
| 2026-05-08 15:01 | — | Sell | Weak momentum and high risk limit upside potential. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-06-03 09:25 | HSBC | Target Lowered | 270 → 230 | 176.11 |
| 2026-05-14 20:22 | RBC Capital | Update | — → 200 | 164.54 |
| 2026-04-21 18:05 | Jefferies | Target Raised | 240 → 245 | 194.45 |
